Testing AV-001 to protect the brain during hemodialysis
Part of Brain & nervous system, Kidney & urinary clinical trials.
This study tests a new medicine called AV-001 to see if it can protect the brain from damage caused by hemodialysis. If you qualify, you may help find a way to reduce thinking and memory problems linked to dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and be a man or a woman who is not pregnant.
- You need to have been on hemodialysis for at least 3 months.
- You must go to hemodialysis 3 times every week.
- You must be able to have an MRI scan (no metal implants, pacemaker, etc.).
- You should not have severe memory problems or a diagnosis of dementia.
- You cannot have had a stroke in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that uses light to check the health of your AV access (the blood vessel connection used for dialysis) without touching it. It may help doctors spot problems early.
This trial tests if using a virtual reality headset can help improve thinking and memory problems in adults on hemodialysis. If you are between 18 and 75, have been on dialysis for at least three months, and can use the headset, you may be able to join.
This trial tests whether taking preventive antibiotics (or a placebo sugar pill) can lower the risk of infections in people who receive hemodialysis through a catheter. It may help protect you from serious catheter-related infections, but you must be able to follow the study’s medicine and consent rules.
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
This study tests a new device that monitors blood flow in the AV fistula (the connection between an artery and vein used for dialysis) to make sure it stays healthy and works well.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.